Brandon Folkes is a Director covering Specialty Pharmaceuticals at Cantor Fitzgerald. Previously, he was a Vice President at Guggenheim Securities. Prior to that, Mr. Folkes was with CRT Capital as a Research Associate. Before becoming a sell-side Equity Research Analyst, he worked for KPMG and PwC. Mr. Folkes holds his CFA Charter and holds an MBA from Mississippi State as well as degrees from the University of South Africa and the University of Stellenbosch.